Revenue
$17.9m
+43.8% ↑ vs $12.4m
Revenue recovery accelerated but investment intensity deepened losses 22.4%, leaving Serko dependent on its fresh capital raise to fund the runway.
Revenue context before the current result.
EBITDA margin across covered periods.
Operating cash flow across covered periods.
Operating working-capital absorption or release by reporting period.
Key metrics
FY22 vs FY21
Revenue
$17.9m
+43.8% ↑ vs $12.4m
Net profit after tax
$0m
flat vs $0m
Net cash inflow from operating activities
−$18.5m
-2.3% ↓ vs −$18m
Profit before tax
$0m
flat vs $0m
Cash and cash equivalents
$0.13m
+257.1% ↑ vs $0.04m
Total assets
$167.2m
+50.2% ↑ vs $111.3m
What changed
Revenue rose 43.8% to NZ$17.9m, with segment revenue of NZ$19.8m beating the midpoint of the NZ$18.5m–NZ$20.5m guidance range, while online travel booking volumes jumped 67% to 2.15 million. Despite that recovery, operating losses widened: NPAT declined 22.4% to a loss of NZ$36.0m and PBT worsened 22.7%, reflecting cost growth that outpaced the revenue rebound. Operating cash outflow was broadly flat at NZ$-18.5m versus NZ$-18.0m a year earlier.
The balance sheet was materially reshaped by the equity raise: cash moved from NZ$34.9m to NZ$124.5m, lifting total assets to NZ$167.2m — NZ$42.9m above the historical mean of NZ$124.3m.
What matters
Capex at 88.9% of revenue versus 58.3% a year ago explains the FCF step-down. The company is deliberately deploying raise proceeds into product and North American expansion rather than managing toward near-term profitability, so the loss widening is investment-phase math, not a deteriorating core business.
Debtor days of 44.2 are meaningfully elevated relative to Serko's own baseline of 18.9–28.7 days. At 21.9 days above the historical mean, this is worth monitoring: in a transaction-volume recovery with growing Booking.com for Business exposure, receivables timing could reflect mix or platform-related settlement lags. If it persists it represents cash-flow slippage on an already negative-OCF base.
The H2 shape showed meaningful improvement. The HY22 interims recorded NPAT of NZ$-15.2m; the implied second-half NPAT was NZ$-20.8m, meaning H2 was the heavier loss period despite a stronger booking environment. This suggests cost step-ups and investment deployment were concentrated in the second half, which matters for the trajectory entering FY23.
Expectations
The 67% growth in online bookings signals improving operating leverage potential as volumes normalise, and management cited average revenue per booking rising 8% to NZ$5.80.
No formal FY23 financial targets are disclosed in this release. The company is in an explicit investment phase with average cash burn of approximately NZ$3.0m per month cited in the presentation materials and NZ$124.5m of cash on hand. The key uncertainty is whether booking-volume momentum can sustain pace sufficient to bend the FCF curve before the company needs to revisit the capital markets.
Quality of result
However, the reported NPAT and FCF are heavily investment-shaped rather than reflective of underlying earnings power. With capex at 88.9% of revenue and capitalised development alone at NZ$15.3m, a significant portion of FY22 spending is being deferred to the income statement via future amortisation. This means reported losses are not a clean read on the cash economics going forward; the amortisation drag will build.
Cash quality is constrained: OCF of NZ$-18.5m was flat year-on-year despite 43.8% revenue growth, implying operating scale benefits were absorbed by cost growth. FCF of NZ$-34.5m against the historical range of NZ$-5.5m to NZ$1.3m is structural at current investment levels. Debtor days of 44.2 against the historical baseline mean of 22.3 days represents the most concrete near-term watch item for cash conversion.
Unresolved
This briefing cannot assess whether the Booking.com for Business channel concentration creates renewal or renegotiation risk that would alter the forward revenue trajectory.
Chat
Ask follow-up questions about Serko's FY22 result.
Informational only. No buy, sell, hold, price-target, or personal financial advice.
Informational only. No buy, sell, hold, price-target, or personal financial advice.
Open to load analytical metrics.
Open to load key metrics.
Annual Report
FY22 / financial reportInvestor Presentation
FY22 / results presentationMarket Release - Cover Announcement
FY22 / results announcementMarket Release - Cover Announcement
FY22 / results releaseAnnual Report
FY21 / financial reportInvestor Presentation
FY21 / results presentationMarket Release
FY21 / results releaseMarket Release - Cover Announcement
FY21 / results announcementFinancial Statements
HY22 / financial reportInvestor Presentation
HY22 / results presentationNZX Appendix 2
HY22 / results announcementResults Announcement - Market Release
HY22 / results release2021 Annual Meeting Results
HY22 / commentaryRelated insights
Cross-company views selected from the metrics in this briefing.
Revenue growth context
Revenue growth was 43.8% for this reporting period.
Dividend coverage and payout pressure
Dividend payout versus NPAT is 0.0%.
Earnings quality and statutory distortions
PBT and NPAT growth diverged by 0.3pp.
ROE and capital efficiency
ROE was -23.8%, +4.9pp versus the prior comparable period.
Get the next Serko briefing and related NZX reporting-season updates by email.